Overview
McDermott was part of the legal team that advised Hayward, Calif.-based specialty drug maker Impax Laboratories Inc. as the owner of CorePharma in Middlesex, N.J., which along with other pharmaceutical companies was sold in a deal worth $700 million and completed on March 10.